tegafur has been researched along with Bone Neoplasms in 97 studies
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 9.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "Between February 1985 and October 1989, 26 patients previously treated for metastatic breast cancer received oral tegafur, at a median daily dose of 1200 mg." | 9.07 | Oral tegafur in the treatment of metastatic breast cancer: a phase II study. ( Kajanti, MJ; Maiche, AG; Pyrhönen, SO, 1993) |
| "For a case of recurrent breast cancer with multiple bone metastasis, an oral pyrimidine fluoride-based anti-cancer drug S -1, and zoledronic acid(a third-generation bisphosphonate formulation), were prescribed in experiments to test their efficacy." | 7.79 | [A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy]. ( Kaneko, M; Murata, T; Yamada, T; Yoshino, H, 2013) |
| "We report a long-term complete response (CR) in a patient with postoperative recurrent breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid." | 7.76 | [Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid]. ( Fujiwara, I; Ichida, M; Matsumoto, M; Mizuta, M; Mizuta, N; Nishiyama, A; Ohashi, M; Sakaguchi, K; Umeda, Y, 2010) |
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 7.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "A 51-year-old female with advanced breast cancer involving multiple bone metastases was daily administered 400 mg of UFT and 20 mg of tamoxifen." | 7.67 | [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen]. ( Endo, F; Ishii, T; Kito, T, 1989) |
| " Pharmacokinetic evaluation suggested continuous exposure to 5-FU by means of oral UFT/LV administration in this combination." | 6.74 | Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer. ( Azuma, T; Chayahara, N; Hirai, M; Inoue, Y; Kadowaki, Y; Kasuga, M; Maeda, T; Miki, I; Nishisaki, H; Okumura, K; Okuno, T; Sakaeda, T; Tamura, T; Tsuda, M; Yamamori, M, 2009) |
| "We recently established a metastasis model in nude mice using the MKL-4 cell line, a contransfectant of the MCF-7 human breast cancer cell line with fgf-4 and lacZ in which micrometastases in several organs can be quantitatively observed." | 5.30 | Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. ( Dickson, RB; Fujioka, A; Fukumori, H; Kurebayashi, J; Kurosumi, M; Nukatsuka, M; Saito, H; Sonoo, H; Takeda, S; Unemi, N, 1997) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 5.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "Between February 1985 and October 1989, 26 patients previously treated for metastatic breast cancer received oral tegafur, at a median daily dose of 1200 mg." | 5.07 | Oral tegafur in the treatment of metastatic breast cancer: a phase II study. ( Kajanti, MJ; Maiche, AG; Pyrhönen, SO, 1993) |
| "For a case of recurrent breast cancer with multiple bone metastasis, an oral pyrimidine fluoride-based anti-cancer drug S -1, and zoledronic acid(a third-generation bisphosphonate formulation), were prescribed in experiments to test their efficacy." | 3.79 | [A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy]. ( Kaneko, M; Murata, T; Yamada, T; Yoshino, H, 2013) |
| "We report a long-term complete response (CR) in a patient with postoperative recurrent breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid." | 3.76 | [Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid]. ( Fujiwara, I; Ichida, M; Matsumoto, M; Mizuta, M; Mizuta, N; Nishiyama, A; Ohashi, M; Sakaguchi, K; Umeda, Y, 2010) |
| "A 59-year-old man diagnosed as gastric cancer with peritonitis carcinomatosa was treated with paclitaxel and TS-1; 60 mg/m(2)/day of paclitaxel was given on days 1 and 8, and 60-80 mg/m(2)/day of TS-1 was given for 2 weeks." | 3.75 | Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric ( Hasegawa, K; Hirono, H; Shibasaki, K; Soga, K; Watanabe, T; Yoneoka, Y, 2009) |
| "A 34-year-old female patient with breast cancer metastasizing to bone had a remission after a course of treatment with medroxyprogesterone acetate (MPA) 1,200 mg/day, but again had a metastasis to the lungs." | 3.68 | [A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy]. ( Harada, N; Kanda, K; Kida, H; Narita, K; Uchimura, M; Waki, S, 1990) |
| "A 51-year-old female with advanced breast cancer involving multiple bone metastases was daily administered 400 mg of UFT and 20 mg of tamoxifen." | 3.67 | [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen]. ( Endo, F; Ishii, T; Kito, T, 1989) |
| " Pharmacokinetic evaluation suggested continuous exposure to 5-FU by means of oral UFT/LV administration in this combination." | 2.74 | Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer. ( Azuma, T; Chayahara, N; Hirai, M; Inoue, Y; Kadowaki, Y; Kasuga, M; Maeda, T; Miki, I; Nishisaki, H; Okumura, K; Okuno, T; Sakaeda, T; Tamura, T; Tsuda, M; Yamamori, M, 2009) |
| "More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited." | 2.73 | Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. ( Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB, 2007) |
| "According to the Japan Mammary Cancer Society's criteria of response, more than partial response was observed in 11 out of 32 cases (34." | 2.65 | [Clinical trial of UFT against disseminated breast cancer]. ( Harauchi, D; Itoh, S; Konishi, Y; Shinoto, M, 1984) |
| "Synchronous bone metastases from early gastric cancer are extremely rare, and a good outcome was achieved in the present case through induction chemotherapy." | 2.50 | [A case of early gastric cancer with multiple synchronous bone metastases treated complete response with S-1+CDDP]. ( Iwanaga, T; Iwasaki, Y; Ohashi, M; Oohinata, R; Takishita, C; Yajima, K, 2014) |
| "We diagnosed advanced gastric cancer with disseminated carcinomatosis of the bone marrow and multiple bone metastasis." | 2.47 | [A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascu ( Ashida, C; Higashida, A; Kawara, F; Kondo, T; Mamori, S; Okutani, T; Onishi, K; Takeda, A; Yamada, H, 2011) |
| "She died from gastric cancer in December 2012." | 1.42 | [A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy]. ( Hamakawa, T; Hoshino, H; Ikeda, N; Kamigaki, S; Kawase, T; Kimura, Y; Makari, Y; Mikami, J; Munakata, S; Nakata, K; Ohzato, H; Tsujie, M; Yamamoto, T; Yamamura, J, 2015) |
| "The tegafur-uracil treatment resulted in the disappearance of pulmonary metastases, and a stabilization of the bone metastases." | 1.40 | [A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival]. ( Abiko, M; Harada, M; Sato, T; Shiono, S; Takanashi, I, 2014) |
| "The patient was diagnosed with advanced gastric cancer accompanied by multiple bone metastases, with compression fractures in the thoracolumbar vertebrae as well as distant lymph node metastases." | 1.38 | [A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy]. ( Chiba, T; Fujiwara, H; Koeda, K; Mitomo, S; Sugai, T; Takahashi, M; Uesugi, N; Wakabayashi, G, 2012) |
| "Advanced gastric cancer (AGC) accompanied by disseminated intravascular coagulation(DIC)has a poor prognosis, and has no established therapy." | 1.38 | [A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel]. ( Harita, S; Kiguchi, T; Kimura, K; Kubo, T; Mannami, T; Masunari, T; Nakata, Y; Ninomiya, K; Okada, T; Seno, S; Sezaki, N; Sonobe, H; Suzuki, Y; Tamura, T, 2012) |
| " To the best of our knowledge, cases of EGC combined with metachronous osteosclerotic multiple bone and bone marrow metastases that respond to chemoradiotherapy are very rare." | 1.37 | Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy. ( Chiba, F; Kiyozaki, H; Konishi, F; Saito, M; Shuto, C; Takata, O; Yamada, S; Yoshida, T, 2011) |
| "We report a case of breast carcinoma with repeated recurrences in the right bone." | 1.37 | [A case of repeated bone metastases of breast carcinoma successfully treated by S-1 chemotherapy]. ( Kinoshita, S; Kyoda, S; Morikawa, T; Okamoto, T; Takeyama, H; Uchida, K; Yamashita, A, 2011) |
| "A 49-year-old female with advanced gastric cancer complicated with peritoneal dissemination underwent distal gastrectomy, and thereafter she was treated with a combined chemotherapy of S-1 and paclitaxel for 5 months, followed by treatment with S-1 alone." | 1.36 | [A case of S-1-resistant gastric cancer with multiple bone metastases and disseminated intravascular coagulation--effective treatment by combined chemotherapy with CDDP and CPT-11]. ( Kitagawa, M; Koh, T; Kondo, Y; Nakagawa, N; Nanri, M; Oguro, A; Yamasaki, J, 2010) |
| "Though chronic hepatitis C was pointed out before, it had been left untreated for about 5 years." | 1.35 | [A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN]. ( Ichikawa, M; Iwakawa, K; Matsumoto, T; Miyauchi, S; Seike, H; Tanaka, Y; Tanisaka, Y; Tsubouchi, E, 2009) |
| "We diagnosed disseminated carcinomatosis of bone marrow by gastric cancer." | 1.35 | [A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP]. ( Fujishima, Y; Fukuda, T; Fukunaga, H; Iwai, M; Koide, M; Miura, M; Yoneda, R, 2009) |
| "Pancreas cancer or gallbladder cancer was suspected by CT, and a high tumor marker score (CA19-9 18,625 U/mL, DUPAN-II 15,000 U/ mL elevations were acknowledged)." | 1.35 | [Marked effect of combination chemotherapy with tegafur-gimeracil-oteracil potassium and gemcitabine on a suspected case of pancreas cancer or gallbladder cancer metastasis to bone: further diagnosis of disseminated carcinomatosa of bone marrow recurrence ( Aoyama, I; Arai, O; Doi, A; Hata, T; Hirao, K; Jinno, A; Katayama, S; Kikuchi, O; Kiyosuke, Y; Maeda, Y; Matsueda, K; Miyoshi, M; Mouri, H; Sakai, A; Tanabe, W; Terashima, Y; Tsuji, Y; Yamamoto, H; Yamamoto, N, 2008) |
| "She was diagnosed as remnant gastric cancer with multiple bone metastasis and peritoneal dissemination." | 1.33 | [A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Tanabe, K; Toge, T; Ukon, K; Yoshida, K, 2005) |
| "A 54-year-old woman who had ascending colon cancer with multiple liver and lung metastases underwent rt." | 1.33 | [A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11]. ( Fujii, Y; Kobayashi, T; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T, 2005) |
| "Endoscopic findings revealed type 3 gastric cancer." | 1.33 | [A case of gastric cancer with DIC caused by multiple bone metastases treated with TS-1]. ( Fujishiro, R; Ichinose, T; Naruse, Y; Sakamoto, R; Yamazaki, A, 2006) |
| "We report a rare patient with a DPD deficiency." | 1.33 | [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency]. ( Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M, 2006) |
| " Furthermore, she was administered tegafur/uracil (400 mg/day) 5 days weekly for pharmacokinetic modulating chemotherapy (PMC)." | 1.33 | [A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy]. ( Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T, 2005) |
| " He was treated with pharmacokinetic modulating chemotherapy (PMC) and low-dose CPT-11." | 1.32 | [A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11]. ( Aihara, T; Fukuhara, A; Kouno, T; Murayama, M; Nakagawa, K; Nakamura, E; Niida, M; Nishimoto, Y; Nozaki, H; Syouda, S; Watanabe, Y; Yagyu, T; Yasuoka, H, 2004) |
| " Since clinical studies have demonstrated that bisphosphonates (BPs), specific inhibitors of osteoclastic bone resorption, are beneficial for breast cancer patients with bone metastases, we next examined the effects of UFT combined with the BP zoledronic acid (ZOL) on established bone metastases." | 1.32 | Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer. ( Hata, K; Hiraga, T; Ikeda, F; Tamura, D; Ueda, A; Williams, PJ; Yoneda, T, 2003) |
| "We report a 48-year-old male with gastric cancer who was suffering from acute onset of DIC due to multiple bone metastases." | 1.32 | [A patient with gastric cancer complicated with severe DIC and multiple bone metastasis showing a high response to combination of TS-1 and CDDP]. ( Fujitani, K; Hirao, M; Kida, H; Tsujinaka, T; Yoshioka, S, 2003) |
| "A standard treatment for hepatocellular carcinoma with extrahepatic metastasis is not established and chemotherapy is ineffective." | 1.32 | [A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy]. ( Aozasa, S; Fujino, K; Hase, K; Ito, H; Okada, K; Shikina, A; Suganuma, T; Tanaka, M; Terauchi, R; Tsuda, T; Utsunomiya, K, 2004) |
| "We recently established a metastasis model in nude mice using the MKL-4 cell line, a contransfectant of the MCF-7 human breast cancer cell line with fgf-4 and lacZ in which micrometastases in several organs can be quantitatively observed." | 1.30 | Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. ( Dickson, RB; Fujioka, A; Fukumori, H; Kurebayashi, J; Kurosumi, M; Nukatsuka, M; Saito, H; Sonoo, H; Takeda, S; Unemi, N, 1997) |
| "A 60-year-old man with renal cell carcinoma and metastases to the right 7th rib and L2 vertebra (T2N0M1, OSS) was treated with interferon-alpha and the uracil and tegafur combination following nephrectomy." | 1.29 | A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response. ( Maehara, Y; Satoh, J; Shibata, Y; Shimizu, TS; Sugihara, S; Uchida, T, 1994) |
| "A 47-year-old man with ascending colon cancer with multiple liver metastases and bone metastasis (VII thoracic vertebra) showed a remarkable response to the combination therapy of tegafur and cisplatin." | 1.29 | [A case of remarkable response of colon cancer with multiple liver and bone metastasis treated with tegafur and cisplatin]. ( Arima, S; Futami, K; Hara, F; Harada, Y; Inada, S; Kotoh, T; Nishida, T; Tateishi, S; Yamasaki, K, 1995) |
| "Treatment of hepatocellular carcinoma with bone metastasis is often ineffective, but this is a rare case showing the clinical effectiveness of oral administration of UFT." | 1.29 | [A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT]. ( Chao, C; Imada, T; Maehara, T; Matsumoto, A; Miyazaki, T; Morinaga, S; Takehana, T, 1995) |
| "At the same time, malignant lymphoma of the liver and several bones were disclosed, but these tumors had become remarkably smaller after chemotherapy, radiotherapy and transcatheter hepatic arterial chemoembolization." | 1.29 | [A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy]. ( Fujioka, S; Kato, K; Tomono, H, 1996) |
| "However, metastatic bone tumors from gastric cancer usually resist any treatments." | 1.28 | [A case of gastric cancer with recurrent bone metastases successfully treated with induced hypertension chemotherapy using cisplatin]. ( Furuya, K; Kashu, Y; Kiyasu, Y; Moriuchi, A; Sakai, K; Satoh, H; Shigematsu, S; Tanaka, T, 1992) |
| "A 66-year-old woman with left breast cancer (medullary carcinoma; T1cN1M0; Stage II A) was treated with breast conserving therapy combined with lumpectomy, radiotherapy, chemotherapy and endocrine therapy beginning in March, 1990." | 1.28 | [A case report of bone metastasis diagnosed by MRI and effectively treated with UFT after breast conserving therapy for breast cancer]. ( Hamada, N; Inomata, T; Nishioka, A; Ogawa, Y; Ogoshi, S; Sawada, A; Tanaka, Y; Terashima, M, 1992) |
| "He was diagnosed as having primary hepatocellular carcinoma with bone metastasis by his high titer (111,683 ng/ml) of serum alpha-fetoprotein, computed tomography and abdominal angiography, and so UFT therapy, 400 mg daily, was instituted." | 1.27 | [A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]. ( Imai, Y; Inada, M; Inui, Y; Kawata, S; Matsuda, Y; Minami, Y; Miyoshi, S; Noda, S; Saito, R; Tamura, S, 1987) |
| "A 35-year-old woman tuffering from gastric cancer associated with disseminated carcinomatosis of the bone marrow is reported." | 1.27 | [Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow]. ( Akimoto, R; Asano, E; Higashino, Y; Kato, M; Mukawa, A; Nagakawa, T; Nakamura, T; Uchida, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (6.19) | 18.7374 |
| 1990's | 20 (20.62) | 18.2507 |
| 2000's | 44 (45.36) | 29.6817 |
| 2010's | 27 (27.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, N | 1 |
| Karayama, M | 1 |
| Inui, N | 1 |
| Yasui, H | 1 |
| Hozumi, H | 1 |
| Suzuki, Y | 2 |
| Furuhashi, K | 1 |
| Fujisawa, T | 1 |
| Enomoto, N | 1 |
| Nakamura, Y | 1 |
| Inami, N | 1 |
| Matsuura, S | 1 |
| Kaida, Y | 1 |
| Uto, T | 1 |
| Matsui, T | 1 |
| Asada, K | 1 |
| Matsuda, H | 1 |
| Fujii, M | 3 |
| Toyoshima, M | 1 |
| Suda, T | 1 |
| Murata, T | 1 |
| Yoshino, H | 1 |
| Kaneko, M | 1 |
| Yamada, T | 1 |
| Imataka, H | 1 |
| Sato, A | 1 |
| Hamada, K | 1 |
| Takeda, N | 1 |
| Nemoto, H | 1 |
| Shiono, S | 1 |
| Harada, M | 1 |
| Abiko, M | 1 |
| Sato, T | 2 |
| Takanashi, I | 1 |
| Takishita, C | 1 |
| Yajima, K | 1 |
| Iwasaki, Y | 2 |
| Ohashi, M | 2 |
| Iwanaga, T | 1 |
| Oohinata, R | 1 |
| Kimura, Y | 1 |
| Makari, Y | 1 |
| Mikami, J | 1 |
| Kawase, T | 1 |
| Hamakawa, T | 1 |
| Hoshino, H | 1 |
| Nakata, K | 1 |
| Yamamoto, T | 1 |
| Yamamura, J | 1 |
| Kamigaki, S | 1 |
| Ikeda, N | 1 |
| Tsujie, M | 1 |
| Munakata, S | 1 |
| Ohzato, H | 1 |
| Senoo, S | 1 |
| Mannami, T | 2 |
| Tamura, T | 3 |
| Fujiwara, N | 1 |
| Ikeda, G | 1 |
| Komoda, M | 1 |
| Ohtawa, Y | 1 |
| Fujimoto, Y | 1 |
| Sato, N | 1 |
| Kambara, T | 1 |
| Waku, T | 1 |
| Kenmotsu, M | 1 |
| Kurimoto, E | 1 |
| Okada, T | 2 |
| Harita, S | 2 |
| Sonobe, H | 2 |
| Ina, K | 1 |
| Kataoka, T | 1 |
| Takeuchi, Y | 1 |
| Fukuoka, T | 1 |
| Miwa, T | 1 |
| Nishio, T | 1 |
| Furuta, R | 1 |
| Masaki, A | 1 |
| Mori, F | 1 |
| Kayukawa, S | 1 |
| Nagao, S | 1 |
| Ando, T | 1 |
| Goto, H | 1 |
| Lee, JL | 2 |
| Kang, YK | 2 |
| Kang, HJ | 1 |
| Lee, KH | 1 |
| Zang, DY | 1 |
| Ryoo, BY | 2 |
| Kim, JG | 1 |
| Park, SR | 1 |
| Kang, WK | 1 |
| Shin, DB | 1 |
| Ryu, MH | 2 |
| Chang, HM | 2 |
| Kim, TW | 2 |
| Baek, JH | 1 |
| Min, YJ | 1 |
| Ito, Y | 1 |
| Osaki, Y | 1 |
| Tokudome, N | 1 |
| Sugihara, T | 1 |
| Takahashi, S | 1 |
| Iwase, T | 1 |
| Hatake, K | 1 |
| Watanabe, T | 1 |
| Hirono, H | 1 |
| Hasegawa, K | 1 |
| Soga, K | 1 |
| Shibasaki, K | 1 |
| Yoneoka, Y | 1 |
| Chayahara, N | 1 |
| Yamamori, M | 1 |
| Kadowaki, Y | 1 |
| Okuno, T | 1 |
| Miki, I | 1 |
| Tsuda, M | 1 |
| Nishisaki, H | 1 |
| Maeda, T | 1 |
| Inoue, Y | 2 |
| Okumura, K | 1 |
| Azuma, T | 1 |
| Kasuga, M | 1 |
| Sakaeda, T | 1 |
| Hirai, M | 1 |
| Kaira, K | 1 |
| Yanagitani, N | 1 |
| Sunaga, N | 1 |
| Imai, H | 1 |
| Utsugi, M | 1 |
| Kawata, T | 1 |
| Hisada, T | 1 |
| Shimizu, K | 1 |
| Ishizuka, T | 1 |
| Mori, M | 2 |
| Sakurai, T | 2 |
| Umemura, T | 1 |
| Jinta, E | 1 |
| Suzuma, T | 1 |
| Yoshimura, G | 1 |
| Shimizu, S | 1 |
| Tanisaka, Y | 1 |
| Seike, H | 1 |
| Matsumoto, T | 2 |
| Tanaka, Y | 2 |
| Tsubouchi, E | 1 |
| Miyauchi, S | 1 |
| Iwakawa, K | 1 |
| Ichikawa, M | 1 |
| Tomita, K | 1 |
| Nishijima, W | 1 |
| Tsukuda, M | 1 |
| Hasegawa, Y | 1 |
| Ishitoya, J | 1 |
| Yamane, H | 1 |
| Homma, A | 1 |
| Tomita, T | 1 |
| Fujishima, Y | 1 |
| Yoneda, R | 1 |
| Iwai, M | 1 |
| Fukunaga, H | 1 |
| Miura, M | 1 |
| Koide, M | 1 |
| Fukuda, T | 1 |
| Kitagawa, M | 1 |
| Oguro, A | 1 |
| Kondo, Y | 1 |
| Koh, T | 1 |
| Yamasaki, J | 1 |
| Nanri, M | 1 |
| Nakagawa, N | 1 |
| Mizuta, N | 2 |
| Sakaguchi, K | 2 |
| Mizuta, M | 2 |
| Ichida, M | 1 |
| Umeda, Y | 1 |
| Nishiyama, A | 1 |
| Matsumoto, M | 1 |
| Fujiwara, I | 2 |
| Suzuki, E | 1 |
| Furuse, J | 1 |
| Ikeda, M | 1 |
| Ishii, H | 1 |
| Okusaka, T | 1 |
| Nakachi, K | 1 |
| Mitsunaga, S | 1 |
| Ueno, H | 1 |
| Morizane, C | 1 |
| Hata, T | 2 |
| Fujino, S | 1 |
| Yanagawa, T | 1 |
| Kitahara, T | 1 |
| Munakata, K | 1 |
| Watanabe, N | 1 |
| Takamoto, K | 1 |
| Miyake, M | 1 |
| Kawanishi, K | 1 |
| Shimizu, J | 1 |
| Ikeda, K | 2 |
| Fujita, J | 1 |
| Iwazawa, T | 1 |
| Akagi, K | 1 |
| Douno, K | 1 |
| Kitada, M | 1 |
| Shimano, T | 1 |
| Yamada, D | 1 |
| Wada, H | 1 |
| Kobayashi, S | 1 |
| Marubashi, S | 1 |
| Eguchi, H | 1 |
| Takeda, Y | 1 |
| Tanemura, M | 1 |
| Umeshita, K | 1 |
| Doki, Y | 1 |
| Nagano, H | 1 |
| Hara, F | 2 |
| Kiyoto, S | 1 |
| Takahashi, M | 3 |
| Takabatake, D | 1 |
| Takashima, S | 2 |
| Aogi, K | 1 |
| Ohsumi, S | 1 |
| Ikarashi, M | 1 |
| Wakabayashi, K | 2 |
| Omori, K | 1 |
| Ishibashi, Y | 1 |
| Aoki, M | 1 |
| Iwama, A | 1 |
| Itoh, Y | 1 |
| Schultheis, B | 1 |
| Strumberg, D | 1 |
| Bergmann, L | 1 |
| Graeven, U | 1 |
| Hanauske, AR | 1 |
| Lipp, R | 1 |
| Schuette, J | 1 |
| Saito, K | 1 |
| Scigalla, P | 1 |
| Scheulen, ME | 1 |
| Tamada, S | 1 |
| Sagara, Y | 3 |
| Baba, S | 1 |
| Yotsumoto, D | 1 |
| Matsukata, A | 1 |
| Andou, M | 1 |
| Rai, Y | 1 |
| Nakamoto, Y | 1 |
| Kayata, Y | 1 |
| Kikawa, Y | 1 |
| Ogata, M | 1 |
| Yamamoto, M | 1 |
| Saito, M | 1 |
| Kiyozaki, H | 1 |
| Chiba, F | 1 |
| Takata, O | 1 |
| Yoshida, T | 2 |
| Shuto, C | 1 |
| Yamada, S | 1 |
| Konishi, F | 1 |
| Nishida, T | 2 |
| Nakano, S | 1 |
| Shida, T | 1 |
| Ootsuka, T | 1 |
| Ogasawara, T | 1 |
| Nakajima, F | 1 |
| Matsuoka, K | 1 |
| Ogawa, T | 1 |
| Nomura, H | 1 |
| Araya, J | 1 |
| Matsushita, S | 1 |
| Yonekura, K | 1 |
| Mera, K | 1 |
| Kawai, K | 1 |
| Kanekura, T | 1 |
| Takeda, A | 1 |
| Kawara, F | 1 |
| Onishi, K | 1 |
| Higashida, A | 1 |
| Mamori, S | 1 |
| Ashida, C | 1 |
| Okutani, T | 1 |
| Yamada, H | 1 |
| Kondo, T | 1 |
| Takeyama, H | 1 |
| Kyoda, S | 1 |
| Yamashita, A | 1 |
| Kinoshita, S | 1 |
| Okamoto, T | 1 |
| Uchida, K | 1 |
| Morikawa, T | 1 |
| Koo, DH | 1 |
| Lee, SS | 1 |
| Moon, JH | 1 |
| Mitomo, S | 1 |
| Koeda, K | 1 |
| Fujiwara, H | 1 |
| Chiba, T | 1 |
| Uesugi, N | 1 |
| Sugai, T | 1 |
| Wakabayashi, G | 1 |
| Ninomiya, K | 1 |
| Seno, S | 1 |
| Kimura, K | 1 |
| Kubo, T | 1 |
| Masunari, T | 1 |
| Kiguchi, T | 1 |
| Sezaki, N | 1 |
| Nakata, Y | 1 |
| Hoshi, S | 2 |
| Ohyama, C | 2 |
| Namiki, S | 1 |
| Hagisawa, S | 2 |
| Satoh, M | 2 |
| Saito, S | 2 |
| Ono, K | 2 |
| Shirasaka, T | 1 |
| Arai, Y | 2 |
| Uchida, Y | 1 |
| Denno, R | 1 |
| Obama, K | 1 |
| Kinoshita, K | 1 |
| Kanai, M | 1 |
| Takabayashi, A | 1 |
| Nishimura, K | 2 |
| Takahara, S | 1 |
| Nonomura, N | 2 |
| Okuyama, A | 2 |
| Yoshioka, S | 1 |
| Tsujinaka, T | 1 |
| Kida, H | 2 |
| Hirao, M | 1 |
| Fujitani, K | 1 |
| Fukuzaki, A | 1 |
| Omatsu, T | 1 |
| Ichikawa, H | 1 |
| Kawahito, Y | 1 |
| Ashihara, E | 1 |
| Yamamoto, A | 1 |
| Kadoya, M | 1 |
| Takegami, T | 1 |
| Takanashi, Y | 1 |
| Naito, Y | 1 |
| Yoshida, N | 1 |
| Sugino, S | 1 |
| Yoshikawa, T | 1 |
| Hiraga, T | 1 |
| Ueda, A | 1 |
| Tamura, D | 1 |
| Hata, K | 1 |
| Ikeda, F | 1 |
| Williams, PJ | 1 |
| Yoneda, T | 1 |
| Hayashi, S | 1 |
| Masuda, H | 2 |
| Karube, H | 1 |
| Ookame, H | 1 |
| Aoki, H | 1 |
| Sakamoto, N | 1 |
| Tanaka, T | 2 |
| Takayama, T | 1 |
| Yagyu, T | 1 |
| Aihara, T | 1 |
| Murayama, M | 1 |
| Nakamura, E | 1 |
| Nozaki, H | 1 |
| Niida, M | 1 |
| Yasuoka, H | 1 |
| Nishimoto, Y | 1 |
| Watanabe, Y | 1 |
| Syouda, S | 1 |
| Kouno, T | 1 |
| Fukuhara, A | 1 |
| Nakagawa, K | 1 |
| Watanabe, O | 1 |
| Shimizu, T | 1 |
| Imamura, H | 1 |
| Kinoshita, J | 1 |
| Okabe, T | 1 |
| Ogawa, K | 1 |
| Haga, S | 1 |
| Suganuma, T | 1 |
| Terauchi, R | 1 |
| Shikina, A | 1 |
| Tanaka, M | 1 |
| Aozasa, S | 1 |
| Utsunomiya, K | 1 |
| Fujino, K | 1 |
| Ito, H | 1 |
| Okada, K | 1 |
| Tsuda, T | 1 |
| Hase, K | 1 |
| Yamashita, N | 1 |
| Shakado, S | 1 |
| Takemoto, R | 1 |
| Nishi, H | 1 |
| Fukumori, K | 1 |
| Fukuizumi, K | 1 |
| Miyahara, T | 1 |
| Sakai, H | 2 |
| Yasumori, K | 1 |
| Muranaka, T | 1 |
| Takami, Y | 1 |
| Saitsu, H | 1 |
| Watanabe, J | 1 |
| Takemura, M | 1 |
| Osugi, H | 1 |
| Lee, S | 1 |
| Nishikawa, T | 1 |
| Fukuhara, K | 1 |
| Iwasaki, H | 1 |
| Ishikawa, T | 2 |
| Mizuno, K | 1 |
| Togashi, T | 1 |
| Watanabe, K | 1 |
| Seki, K | 1 |
| Ohta, H | 1 |
| Kamimura, T | 1 |
| Tanabe, K | 1 |
| Yoshida, K | 1 |
| Hamai, Y | 1 |
| Ukon, K | 1 |
| Hihara, J | 1 |
| Toge, T | 1 |
| Matsuoka, T | 1 |
| Morikage, N | 1 |
| Kobayashi, T | 1 |
| Kuga, T | 1 |
| Nakayama, T | 1 |
| Fujii, Y | 1 |
| Fujishiro, R | 1 |
| Naruse, Y | 1 |
| Ichinose, T | 1 |
| Yamazaki, A | 1 |
| Sakamoto, R | 1 |
| Hashimoto, T | 1 |
| Arai, K | 1 |
| Saze, Z | 1 |
| Takahashi, K | 1 |
| Yamaguchi, T | 1 |
| Matsumoto, H | 1 |
| Yasutome, M | 1 |
| Hiruma, K | 1 |
| Yamashita, Y | 1 |
| Osaki, T | 1 |
| Takimoto, T | 1 |
| Furukawa, M | 1 |
| Inoue, M | 1 |
| Okumura, M | 1 |
| Niju, T | 1 |
| Kijima, T | 1 |
| Kumagai, T | 1 |
| Yoshida, M | 1 |
| Tachibana, I | 1 |
| Kawase, I | 1 |
| Nakajima, H | 1 |
| Nakatsukasa, K | 1 |
| Kobayashi, A | 1 |
| Hachimine, Y | 1 |
| Sawai, K | 1 |
| Masuda, T | 1 |
| Beppu, T | 1 |
| Ishiko, T | 1 |
| Mizumoto, T | 1 |
| Hosaka, S | 1 |
| Nakahara, O | 1 |
| Hayashi, H | 1 |
| Okabe, H | 1 |
| Yamanaka, T | 1 |
| Okabe, K | 1 |
| Takamori, H | 1 |
| Kanemitsu, K | 1 |
| Hirota, M | 1 |
| Baba, H | 1 |
| Idelevich, E | 1 |
| Karminsky, N | 1 |
| Dinerman, M | 1 |
| Katsenelson, RL | 1 |
| Zvi, NB | 1 |
| Baruch, NB | 1 |
| Biran, H | 1 |
| Man, S | 1 |
| Shani, A | 1 |
| Migita, K | 1 |
| Watanabe, A | 1 |
| Sakamoto, C | 1 |
| Nakamura, T | 2 |
| Ohyama, T | 1 |
| Ishikawa, H | 1 |
| Yamamoto, K | 1 |
| Yoneyama, K | 1 |
| Yamada, A | 1 |
| Koshida, Y | 1 |
| Toriumi, F | 1 |
| Murayama, T | 1 |
| Toeda, H | 1 |
| Imazu, Y | 1 |
| Motegi, K | 1 |
| Akamatsu, H | 1 |
| Ooyama, R | 1 |
| Maruyama, S | 1 |
| Iga, N | 1 |
| Shimo, T | 1 |
| Tomii, K | 1 |
| Shoga, K | 1 |
| Kanaya, Y | 1 |
| Yokoyama, N | 1 |
| Nishioka, K | 1 |
| Kobayashi, K | 1 |
| Aoki, T | 2 |
| Hatano, H | 1 |
| Komori, T | 1 |
| Uemura, Y | 1 |
| Kawano, I | 1 |
| Yufu, M | 1 |
| Shien, T | 1 |
| Shimizu, C | 1 |
| Akashi-Tanaka, S | 1 |
| Yonemori, K | 1 |
| Kohno, T | 1 |
| Hojo, T | 1 |
| Ando, M | 1 |
| Katsumata, N | 1 |
| Kinoshita, T | 1 |
| Fujiwara, Y | 1 |
| Sakai, A | 1 |
| Tsuji, Y | 1 |
| Kikuchi, O | 1 |
| Jinno, A | 1 |
| Tanabe, W | 1 |
| Terashima, Y | 1 |
| Maeda, Y | 1 |
| Doi, A | 1 |
| Yamamoto, N | 1 |
| Aoyama, I | 1 |
| Arai, O | 1 |
| Kiyosuke, Y | 1 |
| Katayama, S | 1 |
| Hirao, K | 1 |
| Miyoshi, M | 1 |
| Mouri, H | 1 |
| Matsueda, K | 1 |
| Yamamoto, H | 1 |
| Suzumura, K | 1 |
| Ito, N | 1 |
| Nagata, H | 1 |
| Kotake, K | 1 |
| Arikawa, T | 1 |
| Ando, K | 1 |
| Nakao, N | 1 |
| Kurokawa, T | 1 |
| An, J | 1 |
| Nonami, T | 1 |
| Itoh, S | 1 |
| Konishi, Y | 1 |
| Harauchi, D | 1 |
| Shinoto, M | 1 |
| Moriyama, A | 1 |
| Murata, I | 1 |
| Kuroda, T | 1 |
| Yoshikawa, I | 1 |
| Tabaru, A | 1 |
| Ogami, Y | 1 |
| Otsuki, M | 1 |
| Shimizu, TS | 1 |
| Uchida, T | 1 |
| Shibata, Y | 1 |
| Satoh, J | 1 |
| Sugihara, S | 1 |
| Maehara, Y | 1 |
| Harada, Y | 2 |
| Arima, S | 1 |
| Futami, K | 1 |
| Yamasaki, K | 1 |
| Kotoh, T | 1 |
| Tateishi, S | 2 |
| Inada, S | 1 |
| Chao, C | 1 |
| Imada, T | 1 |
| Takehana, T | 1 |
| Morinaga, S | 1 |
| Miyazaki, T | 1 |
| Maehara, T | 1 |
| Matsumoto, A | 1 |
| Morimoto, T | 1 |
| Sasa, M | 1 |
| Monden, Y | 1 |
| Sakai, S | 1 |
| Minami, Y | 2 |
| Kanetake, H | 1 |
| Saito, Y | 1 |
| Daniels, M | 1 |
| Díaz-Rubio, E | 1 |
| Guillem, V | 1 |
| Montero, JM | 1 |
| García-Conde, J | 1 |
| Estapé, J | 1 |
| Martín, M | 1 |
| Herranz, C | 1 |
| Ordoñez, A | 1 |
| Galán, A | 1 |
| Fujita, K | 1 |
| Matsushima, H | 1 |
| Nakano, M | 1 |
| Kaneko, T | 1 |
| Kajanti, MJ | 1 |
| Pyrhönen, SO | 1 |
| Maiche, AG | 1 |
| Taniwaki, M | 1 |
| Kakusui, M | 1 |
| Imoto, M | 1 |
| Takashima, T | 2 |
| Misawa, S | 1 |
| Kashima, K | 1 |
| Ohta, J | 1 |
| Maruiwa, M | 1 |
| Noutomi, M | 1 |
| Tokuhara, K | 1 |
| Inutsuka, K | 1 |
| Tomono, H | 1 |
| Fujioka, S | 1 |
| Kato, K | 1 |
| Ito, T | 1 |
| Yamada, M | 1 |
| Tanemura, H | 1 |
| Oshita, H | 1 |
| Asano, M | 1 |
| Saji, S | 1 |
| Kurebayashi, J | 1 |
| Nukatsuka, M | 1 |
| Fujioka, A | 1 |
| Saito, H | 1 |
| Takeda, S | 1 |
| Unemi, N | 1 |
| Fukumori, H | 1 |
| Kurosumi, M | 1 |
| Sonoo, H | 1 |
| Dickson, RB | 1 |
| Uehara, T | 1 |
| Yano, T | 1 |
| Kanematsu, T | 1 |
| Terazaki, Y | 1 |
| Kuninaka, S | 1 |
| Fukuyama, Y | 1 |
| Yokoyama, H | 1 |
| Asoh, H | 1 |
| Ichinose, Y | 1 |
| Sadamoto, Y | 1 |
| Koujima, M | 1 |
| Itaba, S | 1 |
| Miyagi, Y | 1 |
| Imamura, M | 1 |
| Motosato, K | 1 |
| Siomichi, S | 1 |
| Amagase, Y | 1 |
| Ogawa, Y | 2 |
| Ogisawa, K | 1 |
| Nagatsuka, I | 1 |
| Matsumura, Y | 1 |
| Yashiro, M | 1 |
| Onoda, N | 1 |
| Nakata, B | 1 |
| Kato, Y | 1 |
| Hirakawa, K | 1 |
| Kusama, M | 1 |
| Kaise, H | 1 |
| Nakayama, S | 1 |
| Oota, D | 1 |
| Shimizu, H | 1 |
| Koyanagi, Y | 1 |
| Ono, Y | 1 |
| Nozawa, M | 1 |
| Fukui, T | 1 |
| Imazu, T | 1 |
| Takaha, N | 1 |
| Sugao, H | 1 |
| Miki, T | 1 |
| Ishihama, H | 1 |
| Kiyasu, Y | 1 |
| Kashu, Y | 1 |
| Sakai, K | 1 |
| Shigematsu, S | 1 |
| Furuya, K | 1 |
| Moriuchi, A | 1 |
| Satoh, H | 1 |
| Nishioka, A | 1 |
| Hamada, N | 1 |
| Terashima, M | 1 |
| Sawada, A | 1 |
| Inomata, T | 1 |
| Ogoshi, S | 1 |
| Shibata, M | 1 |
| Saito, A | 1 |
| Hareyama, M | 1 |
| Morita, K | 1 |
| Taguchi, T | 1 |
| Kanda, K | 1 |
| Waki, S | 1 |
| Uchimura, M | 1 |
| Narita, K | 1 |
| Harada, N | 1 |
| Tsujii, H | 1 |
| Kamada, T | 1 |
| Tsuji, H | 1 |
| Takamura, A | 1 |
| Matsuoka, Y | 1 |
| Usubuchi, H | 1 |
| Irie, G | 1 |
| Endo, F | 1 |
| Ishii, T | 1 |
| Kito, T | 1 |
| Adachi, I | 1 |
| Suzuki, M | 1 |
| Tsuchihashi, T | 1 |
| Yamaguchi, K | 1 |
| Abe, K | 1 |
| Inada, M | 1 |
| Kawata, S | 1 |
| Miyoshi, S | 1 |
| Imai, Y | 1 |
| Saito, R | 1 |
| Noda, S | 1 |
| Tamura, S | 1 |
| Inui, Y | 1 |
| Matsuda, Y | 1 |
| Higashino, Y | 1 |
| Kato, M | 1 |
| Asano, E | 1 |
| Akimoto, R | 1 |
| Uchida, H | 1 |
| Mukawa, A | 1 |
| Nagakawa, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359] | Phase 3 | 111 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)[NCT01917552] | Phase 3 | 870 participants (Anticipated) | Interventional | 2013-08-19 | Recruiting | ||
| Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.[NCT02595320] | Phase 2 | 200 participants (Actual) | Interventional | 2015-10-05 | Active, not recruiting | ||
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| Phase Ⅱ Clinical Study of RALOX or CAPOX Combined With Bevacizumab in the First-line Treatment of Advanced Colorectal Cancer[NCT03813641] | Phase 2 | 100 participants (Anticipated) | Interventional | 2019-01-28 | Recruiting | ||
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for tegafur and Bone Neoplasms
| Article | Year |
|---|---|
[A case of early gastric cancer with multiple synchronous bone metastases treated complete response with S-1+CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; | 2014 |
[A very elderly case of advanced gastric cancer with disseminated carcinomatosis of bone marrow and multiple bone metastasis, diagnosed by extremely elevated serum alkaline phosphatase levels, and treated with low-dose S-1 to avoid disseminated intravascu
Topics: Aged, 80 and over; Alkaline Phosphatase; Antimetabolites, Antineoplastic; Bone Marrow Neoplasms; Bon | 2011 |
[Therapy for hormone-refractory prostate cancer].
Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; | 2002 |
16 trials available for tegafur and Bone Neoplasms
| Article | Year |
|---|---|
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
Phase I and pharmacokinetic study of tegafur-uracil/leucovorin combined with 5-fluorouracil/leucovorin and irinotecan in patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptot | 2009 |
Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2010 |
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carci | 2011 |
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; F | 2010 |
Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Combinations; | 2012 |
Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisp | 2012 |
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; | 2004 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplat | 2007 |
[Clinical trial of UFT against disseminated breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 1984 |
Chemo-endocrine therapy for prostate cancer with bone metastasis. Nagasaki Prostate Cancer Research Group.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone | 1994 |
Phase II trial of UFT activity in pretreated breast cancer patients.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; A | 1993 |
Oral tegafur in the treatment of metastatic breast cancer: a phase II study.
Topics: Administration, Oral; Adult; Aged; Blood Cell Count; Bone Neoplasms; Breast Neoplasms; Female; Human | 1993 |
Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic | 2001 |
[Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1990 |
78 other studies available for tegafur and Bone Neoplasms
| Article | Year |
|---|---|
[A case of recurrent breast cancer with multiple bone metastasis successfully treated with S-1 and zoledronic acid therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphona | 2013 |
[A case of progressive gastric carcinoma accompanied by disseminated carcinomatosis of bone marrow (DCBM)due to bone metastasis, with DIC recovery by administration of S-1 and docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Disease Progr | 2013 |
[A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; H | 2014 |
[A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Female | 2015 |
[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report].
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Neoplasms; | 2015 |
Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 2008 |
Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antimetabolites, Antineoplastic; Bone Neoplasms; Bre | 2009 |
Advanced gastric cancer patient with peritonitis carcinomatosa successfully treated with a combination therapy of paclitaxel and TS-1, but relapsed with multiple bone metastasis and died from rapidly progressive meningitis carcinomatosa--advanced gastric
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Combinations; F | 2009 |
[Effective gemcitabine plus S-1 treatment in elderly non-small cell lung cancer patients with multiple bone metastases].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Sm | 2009 |
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2009 |
[A case of advanced hepatocarcinoma responding to combination therapy of S-1 and PEG-IFN].
Topics: Angiography; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 2009 |
[A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2009 |
[A case of S-1-resistant gastric cancer with multiple bone metastases and disseminated intravascular coagulation--effective treatment by combined chemotherapy with CDDP and CPT-11].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2010 |
[Long-term complete response in a patient with breast cancer and bone and pleura metastases after treatment with a combination of S-1 and zoledronic acid].
Topics: Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonate | 2010 |
[Long-term control of sacral metastasis from rectal cancer with S-1 + radiation treatment (RT) and mFOLFOX6 combination therapy--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Dru | 2010 |
[A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Thera | 2010 |
[A case of rectal cancer with sacrum metastasis treated with S-1 leading to a complete response].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Combinations; Female; Humans; Magnetic Resonan | 2011 |
[A patient with of metastatic breast cancer with a well-controlled quality of life using S-1 therapy as first-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; | 2011 |
[A successful case treated with S-1 and zoledronic acid for multiple bone metastasis of breast cancer].
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms | 2011 |
Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Ne | 2011 |
[A case of multiple bone metastasis of gastric carcinoma accompanying DIC successfully controlled with combination of S-1 and low-dose CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disseminated Intravascula | 2011 |
[A case of multiple metastases breast cancer controlled using S-1 as third-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; | 2011 |
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug Combinations; | 2011 |
[A case of repeated bone metastases of breast carcinoma successfully treated by S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; Female; Humans | 2011 |
[A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Humans | 2012 |
[A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intravascular Coa | 2012 |
[Low-dose cisplatin and UFT for hormone refractory prostate cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Com | 2002 |
[A case of recurrent advanced gastric cancer suggesting the efficacy of TS-1 and CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Chemotherapy, | 2002 |
[A patient with gastric cancer complicated with severe DIC and multiple bone metastasis showing a high response to combination of TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clodronic Acid; Dissemina | 2003 |
Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bio | 2003 |
[A case of advanced gastric cancer with bone metastases and DIC responding to oral administration of TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Signet Ring | 2003 |
Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bo | 2003 |
[A case of advanced gastric cancer with simultaneous multiple bone metastases and double occurrence of disseminated intravascular coagulation successfully controlled with combined chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Co | 2004 |
[A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Coloni | 2004 |
[A case of hepatocellular carcinoma with bone metastasis responding to concurrent TS-1/low-dose cisplatin (CDDP) therapy and radiotherapy].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; B | 2004 |
[A case of hepatocellular carcinoma with bone metastasis treated by TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Cisplatin | 2005 |
[A patient with multiple bone metastases from gastric cancer after an 8-year disease-free interval following gastrectomy].
Topics: Adenocarcinoma; Anastomosis, Roux-en-Y; Antimetabolites, Antineoplastic; Bone and Bones; Bone Neopla | 2005 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ri | 2005 |
[A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modal | 2005 |
[A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colect | 2005 |
[A case of gastric cancer with DIC caused by multiple bone metastases treated with TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Combined Modality Therapy; Di | 2006 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimi | 2006 |
[Clinical efficacy of TS-1 in refractory bone recurrence of a postoperative squamous lung cancer patient].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Squamous Cell; Com | 2006 |
[A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2006 |
[A long term survival case of advanced intrahepatic cholangiocarcinoma treated with multidisciplinary treatment].
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Bone Neoplasms; Catheter Ablation; Chemoembolization, | 2006 |
[A case of multiple bone metastases from gastric cancer treated with combination chemotherapy of S-1 and CDDP].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Admi | 2007 |
[A patient with pulmonary metastasis from breast cancer after surgery who responded to S-1].
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Antimetabolites, Antineoplastic; Biomarker | 2007 |
[A case of gastric cancer with multiple bone metastasis that responded to S-1 with low-dose cis-platinum].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; | 2008 |
[Two patients of progressive gastric cancer accompanied by disseminated carcinomatosis of bone marrow due to bone metastasis with DIC successfully controlled by combination of S-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease Progression; Drug | 2007 |
[A patient with gastric cancer complicated with multiple spinal bone metastases showing a complete remission to combination of S-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Cisplatin; | 2008 |
Clinical efficacy of S-1 in pretreated metastatic breast cancer patients.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms | 2008 |
[Marked effect of combination chemotherapy with tegafur-gimeracil-oteracil potassium and gemcitabine on a suspected case of pancreas cancer or gallbladder cancer metastasis to bone: further diagnosis of disseminated carcinomatosa of bone marrow recurrence
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Bone Marrow Neoplasms; Bone Neoplasms | 2008 |
[A case of lumbar metastases from rectal cancer successfully treated by UFT plus oral leucovorin (LV) therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neopla | 2008 |
Pericardiac metastasis from advanced gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorouracil; Heart Neoplasms; Human | 1995 |
A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Diagnostic Im | 1994 |
[A case of remarkable response of colon cancer with multiple liver and bone metastasis treated with tegafur and cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Colonic N | 1995 |
[A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hep | 1995 |
[Improvement of clinical symptoms by UFT and TAM and a case of bone metastasis from breast carcinoma during pregnancy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Hum | 1994 |
[Ifosfamide in combined hormonochemotherapy on prostate cancer].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 1994 |
[Disease-free survival in a patient with squamous cell lung carcinoma following complete response with the combination chemotherapy of cisplatin and etoposide].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, | 1993 |
[A case of advanced gastric cancer responding to chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cispl | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosp | 1996 |
[Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1998 |
Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.
Topics: Animals; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; | 1997 |
[Outpatient chemotherapy with oral UFT (tegafur and uracil) and cisplatin against metastatic non-small cell lung carcinoma--an effective case].
Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Ne | 1999 |
[A case of advanced hepatocellular carcinoma with lung and bone metastases effectively treated by orally administered UFT].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2000 |
[Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplas | 2000 |
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre | 2000 |
[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast | 2001 |
[A case of gastric cancer with recurrent bone metastases successfully treated with induced hypertension chemotherapy using cisplatin].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Bone and Bones | 1992 |
[A case report of bone metastasis diagnosed by MRI and effectively treated with UFT after breast conserving therapy for breast cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast N | 1992 |
[A case report of multiple bone metastases of breast carcinoma effectively treated with mild chemo-endocrine therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms | 1992 |
[A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neopla | 1990 |
Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, | 1989 |
[A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].
Topics: Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplas | 1989 |
[Bone metastasis in advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Cyclop | 1987 |
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; L | 1987 |
[Effective postoperative chemotherapy of gastric cancer associated with disseminated carcinomatosis of the bone marrow].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Marrow; | 1985 |